LTRN
LTRN
US51654W1018
Lantern Pharma Inc.
Loading chart...

Valuation & History

Quarterly trend of key valuation metrics

Metric
Current (TTM) TTM Baseline
Q2 '26 30.06.2026
Q1 '26 31.03.2026
Q4 '25 31.12.2025
Market & Enterprise Value
Market Cap
12.14M EUR
53.21M EUR
15.42M EUR
34.1M EUR
Enterprise Value
3.29M EUR
46.59M EUR
10.56M EUR
29.76M EUR
Valuation Multiples
Trailing P/E
--
--
--
--
Forward P/E
-0.4x
--
--
--
Price to Sales
--
--
--
--
Price to Book
--
--
4.47x
5.22x
EV/Revenue
--
--
--
--
EV/EBITDA
-0.21x
--
--
--
Price to FCF (P/FCF)
--
--
--
--
EV/FCF
--
--
--
--
FCF Yield
-67.85%
-26.46%
-97.77%
-33.14%
ende